Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases

Molecules. 2021 Dec 3;26(23):7340. doi: 10.3390/molecules26237340.

Abstract

In the past few decades, brain diseases have taken a heavy toll on human health and social systems. Magnetic resonance imaging (MRI), photoacoustic imaging (PA), computed tomography (CT), and other imaging modes play important roles in disease prevention and treatment. However, the disadvantages of traditional imaging mode, such as long imaging time and large noise, limit the effective diagnosis of diseases, and reduce the precision treatment of diseases. The ever-growing applications of inorganic nanomaterials in biomedicine provide an exciting way to develop novel imaging systems. Moreover, these nanomaterials with special physicochemical characteristics can be modified by surface modification or combined with functional materials to improve targeting in different diseases of the brain to achieve accurate imaging of disease regions. This article reviews the potential applications of different types of inorganic nanomaterials in vivo imaging and in vitro detection of different brain disease models in recent years. In addition, the future trends, opportunities, and disadvantages of inorganic nanomaterials in the application of brain diseases are also discussed. Additionally, recommendations for improving the sensitivity and accuracy of inorganic nanomaterials in screening/diagnosis of brain diseases.

Keywords: biomedical imaging; brain disease; inorganic nanomaterial.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / diagnostic imaging*
  • Brain Diseases / diagnostic imaging*
  • Brain Mapping / methods
  • Humans
  • Magnetic Resonance Imaging / methods
  • Nanostructures / analysis
  • Optical Imaging / methods
  • Photoacoustic Techniques / methods
  • Positron-Emission Tomography / methods
  • Tomography, X-Ray Computed / methods